Andrea L. Kasinski

Biochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Loss of SUV420H2 promotes EGFR inhibitor resistance in NSCLC through upregulation of MET via LINC01510”.

Loss of SUV420H2 promotes EGFR inhibitor resistance in NSCLC through upregulation of MET via LINC01510

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.03.17.995951

N/A

0DataRank · unranked

3 citations

Alejandra Agredo, Nadia A. Lanman, Jenna Clingerman, Kayla Gates, Andrea L. Kasinski +1 more

MicroRNA-34a: Potent Tumor Suppressor, Cancer Stem Cell Inhibitor, and Potential Anticancer Therapeutic

Frontiers in Cell and Developmental Biology(2021)10.3389/fcell.2021.640587

N/A

0DataRank · unranked

185 citations

Yunfei Wang, Ruifang Liu, Andrea L. Kasinski, Haifa Shen, Frank J. Slack +2 more

Loss of KMT5C Promotes EGFR Inhibitor Resistance in NSCLC via LINC01510-Mediated Upregulation of MET

Cancer Research(2022)10.1158/0008-5472.can-20-0821

N/A

0DataRank · unranked

61 citations

Alejandra Agredo, Nadia A. Lanman, Jihye Son, Ikjot Singh Sohal, Manvir Bains +5 more

Extracellular vesicles released by non-small cell lung cancer cells drive invasion and permeability in non-tumorigenic lung epithelial cells

Scientific Reports(2022)10.1038/s41598-022-04940-6

N/A

0DataRank · unranked

27 citations

Ikjot Singh Sohal, Zulaida Soto-Vargas, Anjali M. Byappanahalli, Sean E. Humphrey, Hana Kubo +6 more

A first-in-class fully modified version of miR-34a with outstanding stability, activity, and anti-tumor efficacy

Oncogene(2023)10.1038/s41388-023-02801-8

N/A

0DataRank · unranked

66 citations

Ikjot Singh Sohal, Shreyas G. Iyer, Kasireddy Sudarshan, Harish Kothandaraman, Nadia A. Lanman +3 more

Emerging diversity in extracellular vesicles and their roles in cancer

Frontiers in Oncology(2023)10.3389/fonc.2023.1167717

N/A

0DataRank · unranked

41 citations

Andrea L. Kasinski, Ikjot Singh Sohal

Histone 4 lysine 20 tri-methylation: a key epigenetic regulator in chromatin structure and disease

Frontiers in Genetics(2023)10.3389/fgene.2023.1243395

N/A

0DataRank · unranked

30 citations

Andrea L. Kasinski, Alejandra Agredo

Developing folate-conjugated miR-34a therapeutic for prostate cancer treatment: Challenges and promises

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.11.25.568612

N/A

0DataRank · unranked

1 citations

Yunfei Wang, Xiaozhuo Liu, Shan Wu, Moyi Wang, Steven G. Turowski +9 more

Selective targeting of chemically modified miR-34a to prostate cancer using a small molecule ligand and an endosomal escape agent

Molecular Therapy — Nucleic Acids(2024)10.1016/j.omtn.2024.102193

N/A

0DataRank · unranked

34 citations

Ikjot Singh Sohal, Shreyas G. Iyer, Kasireddy Sudarshan, Esteban A. Orellana, Kenan E. Ozcan +4 more

Developing Folate-Conjugated miR-34a Therapeutic for Prostate Cancer: Challenges and Promises

International Journal of Molecular Sciences(2024)10.3390/ijms25042123

N/A

0DataRank · unranked

31 citations

Yunfei Wang, Xiaozhuo Liu, Shan Wu, Moyi Wang, Steven G. Turowski +9 more

Preparing and Evaluating the Stability of Therapeutically Relevant Oligonucleotide Duplexes

BIO-PROTOCOL(2024)10.21769/bioprotoc.4975

N/A

0DataRank · unranked

2 citations

Andrea L. Kasinski, Shreyas G. Iyer

Insight into the mechanisms and dysregulation of KMT5C-H4K20me3 in cancer

Epigenetics(2025)10.1080/15592294.2025.2574007

N/A

0DataRank · unranked

2 citations

Andrea L. Kasinski, Jihye Son